Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets

Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets

Since 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been rapidly spreading worldwide, causing hundreds of millions of infections. Despite the development of vaccines, insufficient protection remains a concern. Therefore, the screening of drugs for the treatment of coronaviru...

Full description

Bibliographic Details
Main Authors: Pei-Chen Yu, Chen-Hao Huang, Chih-Jung Kuo, Po-Huang Liang, Lily Hui-Ching Wang, Max Yu-Chen Pan, Sui-Yuan Chang, Tai-Ling Chao, Si-Man Ieong, Jun-Tung Fang, Hsuan-Cheng Huang, Hsueh-Fen Juan
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Pharmaceutics
Subjects:
docking simulation
severe acute respiratory syndrome coronavirus 2
transmembrane protease serine 2 (TMPRSS2)
3C-like protease (3CL<sup>pro</sup>/M<sup>pro</sup>)
papain-like protease (PL<sup>pro</sup>)
tamoxifen
Online Access:https://www.mdpi.com/1999-4923/14/1/176

Internet

https://www.mdpi.com/1999-4923/14/1/176

Similar Items